EEWOWW is an online personal knowledge management tool. Click to find out more!
5 of 20 articles - Show All
  1. PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma.

    Clinical cancer research : an official journal of the American Association for Cancer Research , Volume 21 , Issue 19 (2015)
    Zamagni E , Nanni C , Mancuso K , Tacchetti P , Pezzi A , Pantani L , Zannetti B , Rambaldi I , Brioli A , Rocchi S , Terragna C , Martello M , Marzocchi G , Borsi E , Rizzello I , Fanti S , Cavo M
  2. Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma.

    European journal of haematology , Volume 86 , Issue 4 (2011)
    Elliott B M , Peti S , Osman K , Scigliano E , Lee D , Isola L , Kostakoglu L
  3. Sodium fluoride PET imaging as a quantitative pharmacodynamic biomarker for bone homeostasis during anti-DKK1 therapy for multiple myeloma

    Blood Cancer Journal , Volume 7 , Issue 10 (2017)
    Wang Y , Yee A , Sirard C , Landau S , Raje N
  4. Bone scan images reveal increased osteoblastic function after bortezomib treatment in patients with multiple myeloma.

    European journal of haematology , Volume 86 , Issue 1 (2011)
    Lee S , Min C , Yahng S , Cho B , Eom K , Kim Y , Kim H , Lee S , Cho S , Kim D , Lee J , Min W , Park C
  5. The effects of bortezomib on bone disease in patients with multiple myeloma.

    Cancer , Volume 120 , Issue 5 (2014)
    Mohty M , Malard F , Mohty B , Savani B , Moreau P , Terpos E
(No collections found)